<?xml version="1.0" encoding="UTF-8"?>
<p id="p0295">The idea of using natural polysaccharides as platforms for vaccine development has grown in academia, especially in the past ten years. Several research groups have explored the potential of polysaccharides to transport antigens and counteract side effects in antiviral vaccines (
 <xref rid="bib3" ref-type="bibr">Barbosa &amp; de Carvalho Junior, 2020</xref>). Now, during a COVID-19 pandemic, platforms for vaccine development have been the focus of numerous researches. Although there is no natural polysaccharide being used as a platform for vaccines against COVID-19, it is evident from the studies that will be evaluated, that polysaccharides are efficient, low-cost, biodegradable and biocompatible platforms.
</p>
